Delivering Alzheimer's Treatment: A Doctor's Perspective

episode

Speaking of Alzheimer's not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Speaking of Alzheimer's

Becoming a Caregiver Overnight: A Daughter’s Viral Story 25 min · 13 Aug 2026

AAIC 2026: Breaking Down the Top Alzheimer's Research Announcements 23 min · 17 Jul 2026

The Healing Power of Music & Alzheimer's 22 min · 18 Jun 2026

All episodes from Speaking of Alzheimer's →

Report any issue

Source

Recorded27 Feb 2025

Publisheranchor.fm ↗

Handlerec:1533710

Show notes

Today we’re joined by Dr. Daniel Press, Chief of the Cognitive Neurology Unit at Beth Israel Deaconess Medical Center (BIDMC), who has been administering Leqembi (lecanemab) to patients since its FDA approval. He discusses his experience delivering the treatment — the process from administering the infusions to monitoring for side effects. He also offers insights into managing expectations, the challenges, and how his patients have responded to this new Alzheimer’s therapy. Need assistance? Call the Alzheimer’s Association 24/7 Helpline (800.272.3900).

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.